<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Findings from clinical and research studies suggest that the overall health-related quality of life of many <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> survivors is good </plain></SENT>
<SENT sid="1" pm="."><plain>However, many survivors report significant <z:e sem="disease" ids="C0033953" disease_type="Mental or Behavioral Dysfunction" abbrv="">sexual dysfunction</z:e> after treatment that may adversely affect their quality of life in survivorship </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: This article examines studies investigating sexual function in men and women treated for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Also included are data on the prevalence and nature of <z:e sem="disease" ids="C0033953" disease_type="Mental or Behavioral Dysfunction" abbrv="">sexual dysfunctions</z:e> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> survivors, the impact of specific treatment modalities for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> on sexual function, and the management of <z:e sem="disease" ids="C0033953" disease_type="Mental or Behavioral Dysfunction" abbrv="">sexual dysfunction</z:e> in men and women </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Published studies investigating <z:e sem="disease" ids="C0033953" disease_type="Mental or Behavioral Dysfunction" abbrv="">sexual dysfunction</z:e> after <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> treatment generally have been limited conceptually and methodologically </plain></SENT>
<SENT sid="5" pm="."><plain>However, findings suggest that the prevalence of <z:e sem="disease" ids="C0033953" disease_type="Mental or Behavioral Dysfunction" abbrv="">sexual dysfunction</z:e> among <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> survivors is high </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="C0033953" disease_type="Mental or Behavioral Dysfunction" abbrv="">Sexual dysfunction</z:e> is often a long-term and late effect of treatment for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The assessment and management of <z:e sem="disease" ids="C0033953" disease_type="Mental or Behavioral Dysfunction" abbrv="">sexual dysfunction</z:e> in men and women treated for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> should be standard practice throughout treatment and in survivorship </plain></SENT>
</text></document>